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Abstract. Cancer results from a sequence of genetic and epigenetic changes
which lead to a variety of abnormal phenotypes including increased proliferation
and survival of somatic cells, and thus, to a selective advantage of pre-cancerous
cells. The notion of cancer progression as an evolutionary process has been
experiencing increasing interest in recent years. Many efforts have been made
to better understand and predict the progression to cancer using mathematical
models; these mostly consider the evolution of a well-mixed cell population, even
though pre-cancerous cells often evolve in highly structured epithelial tissues.
In this study, we propose a novel model of cancer progression that considers
a spatially structured cell population where clones expand via adaptive waves.
This model is used to assess two different paradigms of asexual evolution that
have been suggested to delineate the process of cancer progression. The standard
scenario of periodic selection assumes that driver mutations are accumulated
strictly sequentially over time. However, when the mutation supply is sufficiently
high, clones may arise simultaneously on distinct genetic backgrounds, and clonal
adaptation waves interfere with each other. We find that in the presence of
clonal interference, spatial structure increases the waiting time for cancer, leads
to a patchwork structure of non-uniformly sized clones, decreases the survival
probability of virtually neutral (passenger) mutations, and that genetic distance
begins to increase over a characteristic length scale Lc. These characteristic
features of clonal interference may help to predict the onset of cancers with
pronounced spatial structure and to interpret spatially-sampled genetic data
obtained from biopsies. Our estimates suggest that clonal interference likely
occurs in the progression of colon cancer, and possibly other cancers where spatial
structure matters.
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1. Introduction
Progression to cancer is a process of somatic evolution within the body. The idea
that cancer can be understood as an evolutionary process was already formulated
by Nowell in 1976 [1]; still, relatively little attention has been directed on applying
principles from population genetics to understand and control neoplastic progression
until recently [2, 3, 4, 5, 6, 7].
The progression to cancer may be seen as a multi-stage process [8], where the
various stages are characterized by different phenotypic outcomes conferred by somatic
evolution. Many cancers are typically initiated with a benign transformation of tissue
that later progresses to invasion (malignancy). For instance, in colon cancer, the
observation of low and then high-grade dysplasia (early and late adenoma) is followed
by the formation of a carcinoma [9]. Similarly, Barrett’s esophagus is a condition
where normal squamous esophageal tissue has transformed into cells of intestinal type
(metaplasia), a change associated with chronic gastric reflux; later, the tissue may
proceed to low and then high-grade dysplasia, before an actual carcinoma develops [10].
The waiting time that passes from an initially benign tissue transformation until the
formation of malignant neoplasm (conferring cancerous growth) can last for a few up
to 20 years [9]. Many neoplasms, however, never progress to malignancy during the
lifetime of a patient.‡ The determination of which patients are at risk remains an
open problem. Improved models are required to explain the progression to cancer,
assisting us in interpreting genotyping data from biopsies, and in developing improved
diagnostic tools and interventions.
Here, we are concerned with the genotypic evolution of cancer, rather than
with phenotypic outcomes. Tumorigenesis occurs by accumulation of mutations
in oncogenes, tumor suppressor genes, and genes causing genetic instability in
neoplasms [12]. Neoplasms are abnormal tissue masses with increased proliferation
of cells and may be benign or malignant. A sequence of mutations (or ”hits“, which
may include chromosomal alterations and epigenetic changes, not just DNA sequence
mutations) may lead to the typical hallmarks of cancer§. From an evolutionary
perspective, a neoplasm can be viewed as a large, genetically heterogeneous population
of cells, which acquire heritable genetic and epigenetic alterations, influencing their
survival and reproduction. The fitness of a neoplastic cell is shaped by its interactions
with cells and other environmental factors. Indeed, many of the (phenotypic)
alterations proposed as hallmarks of cancer provide a selective advantage to the
neoplastic cells [13]. Genetic alterations that are advantageous for a neoplastic cell
are normally deleterious to the host and ultimately cause death to both host and
neoplasm. Because somatic abnormalities have differing, heritable effects on the fitness
of neoplastic cells, mutant clones may expand or decrease in size by the principles of
Darwinian evolution, e.g. via natural selection and genetic drift (number fluctuations).
Clonal evolution generally selects for increased proliferation and survival, and may lead
to phenotypes such as invasion, metastasis and therapeutic resistance.
Many mutations seen in neoplasms seem to be selectively neutral, or even
deleterious, while other, so-called driver mutations, confer a selective advantage [15,
‡ For instance, ulcerative colitis is an inflammatory bowel disease, in which only 10% of the patients
eventually develop cancer [11].
§ Hallmarks of cancer include self-sufficiency in growth signals, insensitivity to anti-growth signals,
tissue invasion and metastasis, limitless reproductive potential, sustained angiogenesis, evading
apoptosis and possibly others [13, 14].
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16, 17, 18, 19, 20, 21]. Because new mutations only survive genetic drift with
a probability proportional to their selective advantage, deleterious (and neutral)
mutations likely go extinct. However, large numbers of neutral mutations (so-called
passenger mutations [22]) could avoid extinction by ”hitchhiking“ on the genetic
background of selectively advantageous mutations [23].
While some studies have proposed that only a small number of hits, between 2
and 5, may be required to develop cancer [24, 25], some recent studies on breast and
colon cancer have suggested that the number of hits may be even larger with up to 20
hits [19, 5]. A plausible definition for the waiting time for cancer is the time from the
first presence of a neoplasm, until k hits have been accumulated in at least one cell of
the neoplasm [5].
Figure 1. Two important dynamical regimes may dominate clonal expansions:
Periodic selection (a): Mutations occur so rarely that adaptive (clonal)
waves sweep through the habitat one-by-one. Clonal interference (b):
Frequent mutations lead to simultaneous competition of clones, which collide at a
characteristic ”interference” length Lc. In the presence of such clonal interference,
only few clones may reach fixation, leading to the loss of clones carrying a selective
advantage, thus slowing down evolution [26, 27]. Simulations were carried out on
a hexagonal lattice with side length L = 100 and absorbing boundary conditions
with a selective advantage of s0 = 0.25 and a mutation rate of µ = 10−7 in (a),
and µ = 10−5 in (b). The interference length is determined via Eq. (4) and is
Lc ∼ 29 for periodic selection and Lc ∼ 135 for clonal interference, respectively.
Selective advantages are drawn from an exponential distribution. Small numbers
denotes the time sequence. Colors define different levels of (logarithmic) fitness.
Two contrasting paradigms have been proposed for how driver mutations are
accumulated over time: Periodic selection (Fig. 1(a)) occurs when the waiting time
for a successful mutation is much longer than its fixation time, i.e. the time it takes
a clone to spread throughout the entire neoplasm: in this case, clones expand strictly
sequentially. Vice versa, when the typical fixation time is much larger than the
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waiting time for the next successful mutation, multiple clones, arising on different
genetic backgrounds, may compete with one another to reach fixation (Fig. 1(b)).
In this case, clones collide at a characteristic “interference” length Lc [27], which we
discuss in detail in the Results section. Due to this clonal interference, only a small
number of selectively advantageous mutations reach fixation, while most are lost, thus
leading to a reduced speed of evolution when compared to periodic selection. The
model of periodic selection has long shaped the field of population genetics, partly
because beneficial mutations were thought to be exceedingly rare. However, in recent
years, clonal interference has been found to be of great importance in experimental
studies [28] on microbial evolution. While microbes certainly are quite different from
neoplastic cells, both paradigms of periodic selection and clonal interference have
been suggested to be of significance in describing the progression and dynamics of
cancer [23, 29, 30].
The dispersal of an allele in cancer can generally happen in three ways: i)
cells move between partially isolated sub-populations of proliferative units, ii) locally
invade neighboring tissue, or iii) emigrate as metastatic cells from the primary tumor.
Invasion and metastasis do not occur until the late stage of cancer progression, where
cancerous, abnormal growth is initiated; since we study the progression until cancer
initiation, we focus here on the movement of cells between proliferative units (i).
Intestinal epithelium, as well as the epithelium of Barrett’s esophagus, is organized in
proliferative units called crypts, see Fig. 2(a). Intestinal crypts are thought to contain
only around 8 to 20 stem cells, thus yielding quite a small effective population [31].
Stem cells are long-lived and reside close to the bottom of the crypt where they
keep renewing the crypt. Thus, crypts sub-divide the epithelium into isolated sub-
populations. Over time, stem cells acquire mutations which at some point may
dominate the stem cell population within a crypt.
Figure 2. Clonal expansion is possible via crypt bifurcation, and has been
observed in the human colon [11, 32] and may play an important role in Barrett’s
esophagus [10]. Mutations can occur anywhere within the epithelium but persist
only in stem cells. The number ν of stem cells in a crypt is very small. A
mutation can spread in the stem cells until most stem cells within the crypt
carry that mutation (a). At some point, crypts go through a bifurcation process
(b). Such processes continue throughout the life of the host. If the mutation is
pro-oncogenic, it may lead to a higher proliferation rate and to the spreading of
potentially cancerous mutations over several crypts in the neoplasm. Crypts have
an orifice width δ and are relatively densely packed, with an average spacing ∆.
In certain pre-cancerous conditions, mutant clones can expand over many
crypts [11, 23, 32, 33]. The mechanisms underlying such clonal expansion are not
well understood [16]. Hypotheses include crypt bifurcation (Fig. 2(b)), wounding
with epithelial restitution, dispersal through the basement membrane and stroma into
the base of neighboring crypts, and the more speculative dispersal over the surface of
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the epithelium (’local metastasis’) [16]. However, recent research [11, 32] provide in
vivo evidence for the development of clonal patches (clusters) in the human colon, and
suggests that crypt bifurcation indeed is the mechanism explaining clonal expansion
in pre-malignant epithelial tissue. In particular, it has been shown that in humans,
mutated crypts are clustered together throughout the colon, and that clonal patches
increase in size as patients age [32]. For the purpose of this study, we consider crypt
bifurcation as the mechanism behind clonal expansions.
Evolution in spatially structured populations is significantly different from
evolution in non-structured populations [27]. A crucial feature of adaptation in
spatially structured populations is that advantageous mutations spread in the form
of waves, which were first described by R. A. Fisher [34, 35]. Because these
adaptation waves spread with a constant speed, the width of clones grows linearly with
time [36]; in contrast, this is much slower than the characteristic exponential growth
of Malthusian sweeps in well-mixed environments. Since sweeps are much slower in
spatial environments, growing clones are much more likely to interfere than in well-
mixed populations. In particular, as fixation times are larger in spatially extended
populations, the regime of clonal interference is inflated in structured populations
compared to well-mixed populations. As a consequence, the accumulation rate of
beneficial mutations (adaptation speed) is drastically slowed down [27]. In particular,
it has been shown that, while the adaptation speed in non-structured populations
depends logarithmically on population size and mutation rate, the adaptation speed of
spatially structured populations saturates for large population sizes, thus representing
a strict speed limit of evolution [27]. Because spatial structure may slow down
evolution, we expect that the waiting time for cancer, i.e. the time until k hits have
occurred in a neoplastic cell, is also larger in spatially structured neoplastic tissues.
Various model approaches have been used to estimate the waiting time for
cancer [5, 6, 31, 37, 38]. To our knowledge, so far no model has explicitly accounted
for the spatial structure of neoplasms, where adaptive waves describe the expansion
of interfering clones. We thus extend previous work [5] by using a novel model of
spatial evolution [27] to study the waiting time for cancer. Using parameter values
found in literature, we estimate that clonal interference is an adequate description
of clonal expansion in cancers with spatial structure. Furthermore, we discuss some
characteristic features of periodic selection and clonal interference which may help to
discern the two competing paradigms [30] in experimental data.
2. Model
In the following, we introduce a model which allows for an efficient simulation of many
clonal expansions simultaneously in progress [27, 39]. The neoplastic tissue is modeled
by a hexagonal lattice of constant size N = L × L with absorbing boundaries. Each
lattice site records the identity of the locally dominating genotype in a crypt.
Each simulation is initiated with a crypt population devoid of mutations. New
mutations carrying a selective advantage appear at a rate µ per crypt and crypt
cycle (µ thus represents the combined mutation rate of all stem cells harbored in the
crypt). When a mutation becomes established at position i, the fitness Wi of the
i-th clone is updated according to Wi(t + 1) = Wi(t) · (1 + s). Epistasis is absent.
The neoplasm is assumed to be homogeneous implying selective pressures throughout
the crypt population. The selective fitness advantage s of a mutation is drawn from
an exponential distribution with mean value s0. New mutations survive genetic drift
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(stochastic number fluctuations) with a probability 2s for small selective advantages
s. This relation has been shown to hold for both non-structured [40, 41] and spatially
structured populations [27, 42, 39, 43] under certain simplifying assumptions.
Natural selection is implemented as follows. A crypt at site i in the offspring
generation is replaced by one of its neighboring crypts j from the parent generation
with a probability proportional to its fitness Wj . This has the consequence that,
at the front between two clones with differing genotypes and fitness difference ∆W ,
the fitter clone moves into the territory of the other with a velocity c = c(∆W ).
The replacement rule we use here generates adaptive waves traveling at an average
velocity of c = (1/4)
√
∆W [27]. This relation is consistent with a model due to
R. Fisher [34]; he found that in a spatially extended habitat where individuals migrate
at a rate m between sub-populations, advantageous alleles spread with a velocity of
c = 2
√
m∆W [34, 35].
To compare waiting times between spatially structured and non-structured
populations, we have adjusted the algorithm to allow for simulations of an effectively
well-mixed crypt population: instead of selecting the offspring (crypt) from the nearest
neighbors of a crypt at site i, all neighbors are now replaced with crypts chosen
randomly from any crypt neoplasm. Selection is then carried out as described above,
i.e. offspring is selected proportional to the fitness advantages of the randomly chosen
competing crypts.
In our simulations, we vary the beneficial mutation rate µ per site, the mean
selective fitness advantage s0, and the side length L of the crypt population. Several
variables are measured during or at the end of the simulation. All simulations are
terminated once k mutations have occurred in at least one cell; the simulation time
thus represents the waiting time tk for k hits. We also measure the clonal patch
size which we define as the number of crypts with the same mutation. The speed
of adaptation (rate of fitness increase) is defined as V = 〈logW (t+ 1)〉 − 〈logW (t)〉,
where 〈logW 〉 represents the population average of the logarithmic fitness. We also
quantify the spatial genetic (Hamming) distance as a function of spatial distance, as
we explain further below.
3. Results
3.1. Distribution of the waiting time to cancer
Fig. 3 shows distributions of waiting times for k = 5 and k = 10 hits, for neoplasms
of sizes L = 5 and L = 1000 and a mutation rate µ = 10−4 per crypt and crypt cycle.
When the mutation supply rate for the neoplasm, µL2, is sufficiently small, mutations
occur so rarely that clones expand strictly sequentially and fixate one-by-one. Since
new mutations only survive genetic drift with probability 2s [27, 41, 42], the typical
waiting time for one mutation to occur is given by tmut = (2s0µL2)−1. The expected
waiting time for k hits is then 〈tk〉 = k · tmut, or
〈tk〉 = k/v, (1)
where we introduce the mutation accumulation rate v, i.e. the rate at which hits are
acquired; for periodic selection, it is given by v = 1/tmut.
In the present case of periodic selection, the accumulation of hits may be
understood in terms of k Poisson processes, as explained in Appendix A. The resulting
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distribution of waiting times for k hits is
pk(t) =
tk−1e−t
(k − 1)! . (2)
The rescaled waiting times tk/tmut follow this distribution (solid curve) for small
neoplasms with L = 5 very closely (Fig. 3 (a,b)).
Quite a different picture is obtained for large neoplasms of size L = 1000, see Fig. 3
(c) and (d). Waiting times follow a different distribution than for small neoplasms,
and more importantly, the rescaled expected waiting time 〈tk〉/tmut is several order of
magnitudes larger than for the small neoplasm. How can we explain this qualitative
and quantitative difference?
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Figure 3. The (rescaled) waiting times for k hits, tk/tmut, (histogram bars)
for small and large neoplasm sizes L. When the neoplasm size is small (a,b),
clones reach fixation one-by-one. In this case of periodic selection, waiting
times are distributed according to Eq. (2) (solid curve). Larger neoplasms
increase the mutation supply rate, µL2, and shorten the typical waiting time
for successful mutations to occur, tmut = (2s0µL2)−1. When the neoplasm size
is sufficiently large (c,d), mutations arise frequently and their clones interfere at
a characteristic interference length Lc, given by Eq. (4). However, in this case
of clonal interference (c,d), waiting times are normally distributed (solid curve;
see text). Data represents 1000 realizations with exponentially distributed fitness
effects with mean s0 = 0.05 and mutation rate µ = 10−4 per crypt and cycle,
yielding an interference length of Lc ∼ 17, in agreement with our estimates for
colon cancer (Table 1).
The typical time it takes a clone to reach fixation without clonal interference
is tfix = L/c0, where c0 is the speed of a clonal wave with selection coefficient s0.
When this fixation time is much shorter than the waiting time for the next successful
mutation to arise, tfix  tmut, adaptive waves expand strictly sequentially (periodic
selection). In the opposite case, tfix  tmut, the fixation time is too long for a clone
to reach fixation before other mutations occur on a different genetic background, and
clones interfere (clonal interference). The cross-over between these two regimes is
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given by the condition
(2s0µL
2
c)
−1 = tmut ∼ tfix = Lc/c0. (3)
The transition from periodic selection to clonal interference may be achieved by
varying neoplasm sizes, as is done in Fig. 3: for sufficiently large neoplasms (L = 1000),
the mutation supply rate becomes large, too, until the condition for clonal interference
is fulfilled, i.e. tmut  tfix. This suggests that there is a critical neoplasm size L at
which the cross-over occurs: solving Eq. (3) yields the characteristic interference length
scale [27],
Lc =
(
c0
2s0µ
)1/3
. (4)
The length Lc has an intuitive interpretation as the typical length at which clonal
waves typically collide: when the neoplasm size L is smaller than Lc, waves do not
collide (periodic selection); vice versa, we have clonal interference when L Lc. The
ratio L/Lc compounds the model parameters and represents a measure for the strength
of clonal interference (see Fig. 5). In the simulations shown in Fig. 3, the characteristic
interference length is Lc ≈ 17; thus, we observe periodic selection when L = 5 and
clonal interference when L = 1000. As we discuss below, the relevant bell-like shape of
the (Gaussian) distribution of waiting times for large neoplasms (L = 1000) is related
to the interference of clones.
Figure 4. The logarithmic fitness 〈logW (t)〉, averaged over the entire crypt
population (lattice sites), increases at a constant average rate v·s0 after a transient
time τ (see Ref. [27]). At this point, the number of coexisting clones also starts
to saturate (left inset). After the saturated state, the accumulation rate carries
out a random walk (right inset) around its mean value v (dashed red line), given
by Eq. (6), resulting in the Gaussian distribution of waiting times seen in Fig. 3
(c,d). The relative width of the Gaussian distribution of waiting times scales like
σ/〈tk〉 ∼ (v/k)1/2, see Eq. (8). Vertical dashed lines denote the times at which
k = 5, 10, 20 hits have been acquired. The simulation is carried out with s0 = 0.05,
µ = 10−3 (corresponding to a characteristic interference length Lc ∼ 8) and a
neoplasm size L = 100, until k = 20 hits have occurred.
In our simulation, the neoplasm is initially devoid of mutations. There is a
transient time period where the number of clones increases until the model dynamics
relaxes to a state, where newly arising and extinguishing clones stay in balance.
Because of the present fluctuations, this state corresponds to a (quasi) steady state.
In Fig. 4, we illustrate the transient dynamics for clonal interference by considering
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the time evolution of the average logarithmic fitness 〈logW (t)〉. The transient period
may be divided into three stages: (i) until the first successful mutation appears in
the neoplasm (t < tmut), no change in fitness is observed; (ii) first mutations arise,
the number of spreading clones begins to increase and the neoplasm is gradually
populated; the fitness increases first slowly and then at an accelerating rate; (iii) once
clones collide, the number of clones begins to saturate (left inset). Similarly, the rate
of evolution v saturates and fluctuates around a constant mean saturation value (right
inset), given below by Eq. (6).
The observation that the number of coexisting clones first undergoes strong
growth, and then begins to saturate, gives us a hint as of how large the transient
time τ might be: it appears to be related to the time until several clonal waves begin
to interfere (thus, the rate of fitness increase also saturates), suggesting a time scale
of order
τ ∼ Lc/c0 =
(
1
2s0 µ c20
)1/3
. (5)
Additional simulations, where we have varied both the mean selective advantage s0
and mutation rate µ over two decades, have indeed consistently exhibited transient
times of this order.
We have observed above that the distribution of waiting times tk for clonal
interference differs from the distribution for periodic selection. In Fig. 4, after the
transient time has passed, the accumulation rate randomly fluctuates around a mean
value (given below in Eq. (6)). Waiting times tk are well-fitted by a Gaussian
distribution, see Fig. 3 (c) and (d) (This indicates that the fluctuations in the
accumulation rate are correlated over times that are short compared to the total
waiting time.). Even after observing only a low number of hits, k = 5, where
transient behavior could potentially affect the dynamics of clonal expansions, the
fit is surprisingly good. An estimate for the width of this distribution is found further
below in Eq. (8).
3.2. Waiting time in non-structured versus spatially-structured populations
Fig. 5 illustrates how the expected waiting time 〈tk〉 depends on the rescaled
(relative) neoplasm size L/Lc. For periodic selection, when L < Lc, the rate-
limiting step is given by the waiting time for the next successful mutation. This
time tmut = 1/(2s0µL2) is valid for both spatially structured and non-structured
populations. Accordingly, the expected waiting time for periodic selection scales like
〈tk〉 ∼ k tmut ∼ L−2 for both structured and non-structured populations.
For large neoplasms clonal interference becomes relevant, and we observe in Fig. 5
that the waiting time for k hits is shorter for non-structured crypt populations (red
and green) than for spatially structured populations (black and blue). This means
that, in the same time period, fewer hits can be acquired in a spatially structured
compared to a non-structured population.
This observation can be explained by the results from a study on the adaptation
speed for spatially structured populations [27]. Due to the wave-like spread of
clones, the accumulation rate of mutations is much lower in spatially structured when
compared to non-structured populations. For clonal interference, the accumulation
rate is given by [27]
v ∼ 2s0L2cµ ∼ (2 s20 c20 µ)1/3. (6)
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Figure 5. The average waiting time for the accumulation of k = 5 and k = 10
driver mutations is associated with the waiting time for cancer. For periodic
selection (L < Lc), the rate-limiting step is for both well-mixed and spatially
extended populations given by the waiting time for the next successful mutation
tmut. The waiting time is thus 〈tk〉 = k · tmut (the mismatch in the data for non-
structured and structured populations is due to the finite size effects for small
neoplasm sizes). For clonal interference, the waiting time for k hits is markedly
longer for spatially structured (black) than non-structured populations (red).
The discrepancy between non-structured and spatially structured populations
increases for larger number of driver mutations k. Error bars indicate the
sample standard deviations σ(tk). The inset displays how the relative (sample)
standard deviation σ(tk)/〈tk〉 depends on the neoplasm size L. Notice that
fluctuations around the mean are smaller in the clonal interference than in the
periodic selection regime (see inset). Simulations were carried out with absorbing
boundaries and exponentially distributed selective advantages. We have chosen a
selective advantage of s0 = 0.05 and a mutation rate of µ = 10−4, such that the
characteristic interference length Lc ∼ 17 falls into the range of values we have
estimated for pre-malignant tissues in the colon (see Table 1).
This rate differs in two fundamental ways from the rate for non-structured (i.e. well-
mixed) populations [26, 5]: (i) while for periodic selection, the accumulation rate
of mutations grows linearly with neoplasm size v = t−1mut ∼ L2 , it becomes strictly
independent of the neoplasm sizes, constituting a strict speed limit of evolution for
large neoplasms [27]; (ii) the accumulation rate obeys a power law in the mutation
rate µ. This strongly contrasts with the speed in a well-mixed population [26, 5],
where the accumulation rate depends in a logarithmic way on both mutation rate and
mean selective advantage. (The waiting time for the spatial case in Fig. 5 exhibits a
weak dependence on the neoplasm size L, presumably due to the transient behavior
discussed above.) When transients do not matter or are negligible (for instance for
large numbers of hits k), the waiting time for k hits for clonal interference can be
approximated by
〈tk〉 ≈ k
v
. (7)
A more general formula may possibly be cast into the form 〈tk〉 ∼ τ + (k − k˜(τ))/v,
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where k˜ is the average number of hits acquired during the transient time τ . At this
time, we have no prediction for this more general case including transient behavior;
we hope to address this question in a future study.
Finally, using Eq. (7), we estimate the width of the distribution of waiting times
for clonal interference (Fig. 1 (c,d)). As a consequence of the random (short-time)
fluctuations of the accumulation rate, the variance in waiting times grows linearly
with the mean waiting time, i.e. σ2 ∝ 〈tk〉 ∝ k/v. Thus the relative width of the
distribution scales like
σ
〈tk〉 ∝
√
v/k. (8)
3.3. Distribution of clonal patch sizes
We investigate the size of clonal patches, defined as the number of crypts A carrying
the same mutation. For periodic selection, patch sizes are uniformly distributed within
[0, L2], provided that sampling occurs at arbitrary times. When clones interfere,
however, patch sizes are non-uniformly distributed as shown in Fig. 6. We find that
the mean clonal patch size is 〈A〉 ∼ L2c , justifying our above interpretation of Lc as
the typical size of clones.
Figure 6. Distribution of rescaled clonal patch sizes after k = 5 and k = 10
hits have occurred (clonal interference). The patch size A is defined as the
number of crypts carrying the same mutation. The mean clonal patch size
is of order L2c . Data represents 1000 realizations with a neoplasm width of
L = 1000, exponentially distributed selective advantages with mean s0 = 0.05,
and a mutation rate of µ = 10−4 (yielding an interference length of Lc ∼ 17, in
agreement with estimates in Table 1). Clonal patches of 1 are excluded, since the
patch at the end of the simulation always has size 1, thus generating an unrealistic
bias.
3.4. Genetic distance versus spatial distance
Genetic sequencing of several clones within a neoplastic tissue [11, 32] allows to
measure the genetic distance between clones. Here, we investigate whether this genetic
distance depends on spatial distance in the tissue. We define the genetic distance
n between two crypts as the number of mutations by which they differ (Hamming
distance). Since no crypt possesses more than k mutations at the end of a simulation,
the genetic distance is bounded by 0 ≤ n ≤ 2k. The average genetic distance between
two crypts, given a distance (p, q), is then computed via
g˜pq =
1
Λpq
∑
(i,j)
n[(i, j), (i+ p, j + q)], (9)
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where the sum is carried out over all lattice points (i, j) such that (i + p, j + q)
lies within the neoplasm (i.e. a member of the simulated lattice); Λpq represents the
number of points over which the sum is carried out for each tuple (p, q). To obtain a
radial correlation function g(r), distances are binned into groups of [r, r + ∆r[ with
r =
√
p2 + q2 and ∆r = 1. For (p, q) = (0, 0), crypts are identical and we have
n[(i, j), (i, j))] = 0 and g(0) = 0. Since the genetic distance can at most be n = 2k, so
is also g(r) bounded by 2k. Fig. 7 shows that the genetic distance g(r) attains maximal
value; remarkably, this maximal genetic distance increases with smaller mutation rates
µ. The genetic distance begins to increase (i.e. the genetic correlation decays) on the
scale of the characteristic interference length Lc.
Figure 7. Genetic (Hamming) distance (number of differing mutations in
two crypts) increases as a function of spatial distance over the characteristic
interference scale Lc (for clonal interference). The genetic distance g(r) in the
figure represents the average genetic distances found within a radial interval
[r, r + ∆r[ with binning width ∆r = 1, and is calculated after k = 5 (a) or
k = 10 (b) hits have occurred. Each curve represents the ensemble average over
100 realizations; standard errors are too small to be seen on this plot. Simulations
were carried out for neoplasms with side length L = 316, exponentially distributed
selective fitness effects with mean s0 = 0.05, mutation rates µ = 10−4, 10−3, 10−2
per crypt and a crypt cycle, corresponding to Lc ∼ 4, 8, 18.
3.5. Distribution of selective advantages of sweeping mutations
Our model assumes an exponential distribution of fitness effects for the selectively
advantageous mutations. One may wonder which fitness effect distribution will be
found in those clones that eventually drive tumor progression. In general, in the clonal
interference regime, this distribution should deviate from the exponential distribution,
because mutations with small effect will not help in the competition with other clones.
Fig. 8 shows the distribution of selective fitness effects of the mutations that have
hit the ”winning“ clone. When the simulation terminates with the appearance of k
hits, selective fitness advantages are sampled from the crypt where the k-th hit has
occurred (we exclude the fitness coefficient s that is due to the terminating hit).
For periodic selection, the distribution has a similar shape as the exponential
distribution from which selective advantages are drawn during the simulation, see
Fig. 8 (a). However, due to genetic drift (number fluctuations), mutations only survive
with a probability of 2s, which biases the original fitness distribution. The mean
selective fitness is larger than the mean of the exponential distribution s0 from which
selective coefficients are drawn.
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A rather different picture is seen for clonal interference: the distribution of
fitness effects has strongly changed, both in non-structured and spatially structured
populations of crypts, see Fig. 8 (b) and (c). It is seen that mutations with small
fitness advantage are less likely to survive for clonal interference than for periodic
selection. As a consequence, the mean value of the fitness effects is larger for clonal
interference than for periodic selection. The loss of nearly neutral mutations is often
discussed in the context of (nearly) neutral passenger mutations [6].
Interestingly, the distributions for the spatially structured and the well-mixed
case are markedly different. The distribution for the spatially structured case exhibits
a second local maximum in the distribution for large values of s. This hump is even
more pronounced for longer simulation times, i.e. when k = 10 hits have occurred
(Fig. 8(c)). In the spatially structured population, the mean value 〈s〉 is almost
twice as large. The influence of clonal interference on the survival of selectively
advantageous mutations has recently been studied theoretically in detail for non-
structured populations [44]; remarkably, we find here that in spatially structured
populations, large effect mutations are more likely to survive than almost neutral
mutations, when compared to non-structured populations.
Figure 8. Distribution of fitness effects of mutations in the terminating
(”winning“) clone with k = 5 and k = 10 hits. For periodic selection
(L = 5), the shape of the fitness distribution is similar to the exponential
distribution from which effects are drawn during the simulation (a); no significant
difference is discernible in the fitness distribution for non-structured (blue) and
structured populations (red). However, when clones interfere (L = 1000), the
following observations are made (panels (b) and (c)): (i) the mean 〈s〉 is larger,
demonstrating that (ii) almost neutral mutations are less likely to survive than
for periodic selection, and (iii) distributions for non-structured and spatially
structured populations have markedly different shapes: the distribution of fitness
effects exhibits a distinct bimodal structure for the spatially structured case, and
the associated mean selective advantage is approximately twice as large as in the
non-structured population. 500 Simulations have been carried out with selective
fitness effects drawn from an exponential distribution with mean s0 = 0.05 and
a mutation rate of µ = 10−4 (i.e. Lc ∼ 17, in agreement with our estimates for
colonic tissue in Table 1).
3.6. Estimating Lc for pre-cancerous tissue
In the following, we estimate the characteristic interference length Lc for pre-malignant
conditions related to colon cancer, for which parameters are available, to assess
whether clonal interference is likely. Based on these parameters, we provide an
estimate for a lower and an upper bound of the interference length Lc and compare
them with typical sizes of neoplasms in colon cancer.
Spatial structure increases the waiting time for cancer 14
Units of length and time. We measure length in units of crypt spacings, and time
in units of crypt cycles. Crypts in the colon have typically an average diameter of
approximately δ ∼ 0.05 mm [45]. Crypts need not be packed perfectly dense, and lie
at most a few orifice widths δ apart (Fig. 2 (b)). We therefore consider a range for
the crypt displacement ∆ of about two to four crypt diameters, i.e. ∆ ∼ 2δ . . . 4δ.
Typical turn-over times for crypts in diseased colonic tissue lie in the range of 50 to
200 days [46]; this rate is significantly higher than in normal healthy tissue where
crypts have been observed to divide only once every 9 to 17 years [46, 47].
Mutation rate. In our model, we consider the crypts as local proliferative units,
and account for the kinetics of crypts rather than individual cells. In what follows,
we therefore estimate the mutation rate µ per crypt and crypt cycle using a simple
formula (Eq. 10).
Estimates for mutation rates in human cells lie in the range of u = 10−7 . . . 3×10−6
per gene and cell division [5, 6, 8, 31, 48]. However, the human genome consists of
a large number of genes, but not all mutations necessarily lead to cancer. Different
mutation patterns have been observed in different cancer types, and are subject to
considerable variation between patients [19, 21]. Thus, there exists a subset of target
genes that ultimately may lead to the growth of carcinoma, for instance by deactivation
of specific tumor suppressor genes. Analysis of genotype data obtained from colorectal
and breast cancer patients [19] leads to an estimate of d ∼ 40 to 100 target genes.
Only a fraction of these target genes are altered in a patient during progression to
cancer [5, 6]. An estimate for the effective mutation rate for target genes is given with
u× d.
Crypts in the colon typically harbor around 2000 cells of various type [31, 49],
but only a small number of long-lived stem cells. The turnover of cells within the
crypt is high [50], and stem cells are the only cell type that remains in the crypt long
enough to acquire sufficient carcinogenic mutations. Colonic crypts typically harbor
ν = 8 . . . 20 stem cells [31, 47, 49]. Accordingly, we estimate the mutation rate per
crypt and crypt cycle as follows,
µ = u d ν
T
τ
= 5× 10−4 . . . 0.4 per crypt and crypt cycle, (10)
where d is the number of target genes, ν the average number of stem cells in a crypt,
T the length of a crypt cycle and τ the duration of a cell division.
Velocity of adaptation waves. Details of the crypt bifurcation process are not well
understood [16], and measurements of the expansion velocity of clones are not available
at this time. To estimate their velocity, we use the velocity relation valid for our model,
i.e. c ∼ √∆W where we let ∆W = s0. The front of adaptive waves thus move faster
the larger the fitness difference ∆W is along two neighboring regions inhabited by
different clones.
The selective advantage of mutations is generally difficult to measure [51], and
values based on experimental data from neoplastic tissue are unavailable. Some
studies have used simulation models to infer the mean selective advantage s0 by
matching the expected waiting time 〈tk〉 [5, 6], based on a number of assumptions.
Similar to previous studies [5, 6], we consider a relatively large range of values of
s0 ∼ 0.001 . . . 0.1. Using these values, we have an adaptive wave velocity of
c ∼ 0.03 . . . 0.3 crypts per crypt cycles. (11)
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Parameter symbol min max References
mutation rate [per cell division per gene] u 10−7 3× 10−6 [31, 5]
number of stem cells in crypts ν 8 20 [49, 47, 31]
number of target genes d 40 100 [6, 5]
crypt bifurcation time [days] T
ulcerative colitis: 50 105 [46]
Crohn’s disease: 100 200 [46]
multiple polyposis: 110 230 [46]
stem cell division time [days] τ 3 3 [47]
mutation rate [per crypt and cycle] µ 5× 10−4 0.4 [see text]
mean selective advantage s0 10−3 0.1 [5, 6]
wave velocity [crypts / cycle] c0 0.032 0.32 [see text]
interference length [crypts] Lc 1.5 30 [see text]
neoplasm diameter [crypt distance] L 50 500 [see text]
Table 1. Adaptive clonal waves collide at the characteristic interference length
scale Lc. Here we list parameters as obtained for the human diseased colon which
were used to estimate the interference length Lc. When the size of the neoplasm
size L exceeds the characteristic interference length Lc, adaptive waves collide
and compete with each another in going to fixation.
Due to the cube root law in Eq. (4), the interference length Lc depends very
weakly on the key parameters (wave speed c0, mutation rate µ and mean fitness effect
s0). The rather large value range for s0 considered here does therefore not strongly
affect the estimate for Lc. In particular, with a clonal wave speed with c ∼
√
s, we
have Lc ∼ s−1/60 , rendering estimates even more insensitive to variations in s0. For
instance, there is evidence that specific cancer related genes may yield a very large
fitness coefficient of s ∼ 1 [52]; however, even such a large selective advantage does not
strongly alter our estimate for Lc, and only decreases the lower estimated boundary
to Lc ∼ 1.
Interference length Lc and size of neoplasms. Using Eq. (4) and the parameter values
from Table 1, we estimate a lower bound of the characteristic interference length with
s0 = 0.1, µ = 0.4, and an upper bound with parameters s0 = 10−3, µ = 5× 10−4. We
thus find the following range for the characteristic interference length,
Lc ∼ 1.5 . . . 30 crypts. (12)
This range includes mean patch sizes measured in a study on clonal expansions in the
colon [32]. In our simulations, we have chosen parameters resulting in a characteristic
interference length Lc ∼ 17 (except when varying Lc or stated otherwise).
To assess whether clonal interference is likely to occur, we compare our estimate
of Lc with the typical neoplasm size L in the colon. Crypts are relatively densely
packed and have an orifice width of around δ = 0.05 mm [45]. Assuming that the
crypt spacing is of the order ∆ ∼ 2δ . . . 4δ, we get a crypt density of 5 to 10 crypts per
mm (this is also in line with a recent measurement of 16 crypts per square mm in the
sigmoid colon [53]). The diameter of an adenoma lies in the range of 10 to 50 mm [54],
corresponding to a diameter ranging from 50 to 500 crypts. These neoplasm diameters
are larger than the characteristic interference length we have estimated above. We
therefore conclude that clonal interference likely occurs in neoplasms related to colon
cancer, and possibly in other pre-cancerous tissues with spatial character.
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Parameters for Barrett’s segment are subject of current research; one may however
speculate that parameters are similar to those in the colon, because the epithelial
structure have similar (intestinal epithelial) character. Barrett’s segment extends
typically over a length of 1 cm to 10 cm [55], and has a circumference of around
8 cm (quarter-dollar coin). Assuming a crypt density similar to the diseased colon,
one finds an average width of 150 to 900 crypts and thus Barrett’s segment may also
be subject to clonal interference.
4. Discussion
The modeling of carcinogenesis has a long history since its introduction more than
50 years ago [24, 56]. Recently, several studies have focused on the waiting time to
cancer [5, 6, 37], which may be defined as the time until a critical number of hits
(driver mutations) are accumulated and initiate the growth of carcinoma. While most
of these theoretical studies have considered well-mixed populations exclusively, our
study considers neoplastic progression in tissues with pronounced spatial structure.
Although it is reasonable to assume that somatic cell populations are well-mixed in
certain cancers, such as blood cancer, other precancerous tissues have distinct spatial
structure, which has important implications for the way in which clones expand. For
instance, neoplasms in colon cancer and in Barrett’s esophagus are organized into
proliferative units called crypts [16, 57, 47], which divide the epithelial tissue into sub-
populations of stem cells. In the colon, evidence has recently been found that clones
expand via crypt bifurcation [11, 32].
Clonal expansions in spatial structures can be modeled by the spread of adaptive
waves, which were first introduced by Fisher [34]. Such waves travel at a constant
speed through the neoplasm [34, 35, 58]. This ”ballistic“ spreading is markedly slower
than in non-structured populations, where clones obey (exponential) Malthusian
growth. As a consequence of this slower progression, clonal waves are more prone to
interfere, and may lead to slower adaptation speeds in comparison to non-structured
(well-mixed) populations [27]. We found that spatial structure - compared to non-
structured cell populations assumed in other studies [5, 6] - increases the waiting
time to acquire a given number of k hits (i.e. driver mutations). The discrepancy
of waiting times between well-mixed and spatially structured cell populations grows
for larger hit numbers. A frequently debated question is how many hits (driver
mutations) are required to initiate cancer, and figures range from 2, 5 and up to
20 hits [5, 15, 19, 18, 20]. Our finding shows that the number of hits that can be
acquired during a human lifetime must be lower for spatially structured neoplasms
than when assuming a well-mixed structure of the neoplasm. Parameter estimates,
such as for the mean selective fitness advantage found by matching the hit number
k, may thus need to be revised for spatially structured cancers with spatial structure,
too.
Our spatial model allows us to predict characteristic structural features of
neoplastic tissue. When clones interfere, our model predicts that neoplasms are
subdivided into clonal patches, which are non-uniformly distributed with a typical
average size L2c (Eq. (4)). This is consistent with a recent experimental study which
finds that mutated crypts form clusters in the human colon [32]. Moreover, our
investigations on the genetic (Hamming) distance between crypts as a function of
spatial distance have revealed that the genetic distance starts to increase over the
characteristic interference length Lc. Remarkably, the maximal genetic distance is
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found to increase with decreasing mutation rate. Using genetic sequencing methods,
it should be possible to measure genetic distances between samples from different
locations in neoplastic tissue, and to test for the features of clonal interference we
report here. Indeed, recent studies on clonal expansions in the human colon [11, 32]
have introduced promising methods to measure the size of clonal patches using
sequencing methods.
The distribution of waiting times is different for clonal interference than for
periodic selection, where clonal waves sweep strictly sequentially. While the waiting
times obey a Poisson-like distribution for periodic selection, they follow a Gaussian
distribution for clonal interference. The waiting time for cancer progression is
(experimentally) often unknown, since the precise time of initiation of a pre-malignant
condition stays undetected. It may be possible, though, to tie the distribution of
waiting times to the age distribution of cancer outbreak [59], using statistical models.
When clones interfere, mutations with small effect are less likely to survive [44]
than for periodic selection, because they contribute little to the competition between
clones. Remarkably, for spatially structured populations, we have found that this effect
is even stronger, and that the distribution of fitness effects of sweeping mutations has
a bimodal shape. It will be interesting to investigate this phenomenon in a future
study, in the context of passenger mutations and their role in cancer progression [6].
Two different paradigms of asexual evolution - periodic selection and clonal
interference - have been suggested as potential models for cancer progression [30].
Ultimately, knowing the appropriate model of cancer progression not only improves
our theoretical understanding, but will also be very valuable for the interpretation of
genotyping data obtained from biopsies. We have discussed multiple characteristic
features of clonal interference and differences to periodic selection that may assist in
deciding this question.
We have estimated the characteristic interference length Lc for neoplasms in the
colon. When Lc – the the typical length scale at which adaptive waves interfere [27]
– is smaller than the neoplasm size L, clones interfere. Using available parameters
for the diseased colon, we have estimated the characteristic interference length to be
in the range of 1 to 30 crypts. This is considerably smaller than neoplasms in the
colon, and we therefore expect that clonal interference likely occurs, and that it also
may play an important role in other cancers with spatial structure. Our estimates
depend on rough estimates of the selective advantages of driver mutations, as well as
the spreading velocity of clones by crypt bifurcation. However, the interference length
depends only weakly on parameters (with a cube root law), and therefore uncertainties
regarding parameters only have a small influence on our estimate of Lc. Due to this
insensitivity of Lc on parameters, it should be possible to assess Lc for other cancers
with spatial character, too.
It is interesting to think about the role of metastasis in the context of clonal
interference. When metastasis occurs at a late stage of cancer development, cancer
cells disperse to far distant organs of the body and proliferate there. This means
that these cells are capable of spreading in quite different environments and that
their proliferation relies on a variety of mechanisms. However, if one considers only
a single organ (e.g. colon), or ’mid-range’ migration of cells within the same or
neighboring neoplasms, metastasis takes place within identical environments. Long-
range migration (i.e. any form of spatial mixing) strongly increases the speed of
evolution [27]: by generating multiple seeds far off the originating clone, the effective
cumulated sweeping speed becomes larger. As a consequence, clones are less likely to
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interfere, and the accumulation rate of mutations increases. One may speculate that
this is the reason why the phenotype of metastasis confers a selective advantage.
Mortality rates in many cancers have fallen only slowly since the declaration of
the ‘war on cancer’ in 1971 [60]; novel approaches to both therapy and prevention
are needed. Currently, genotyping data from biopsies becomes increasingly available.
Better spatial and temporal resolution in genetic data may significantly improve
our understanding of clonal expansions and prediction of cancer progression. By
demonstrating the important role of spatial structure in progression of some cancers,
we hope to contribute an important element to the ongoing research and fight on
cancer.
Appendix A. Waiting time distribution for k hits for periodic selection
For periodic selection, the accumulation of k hits may be understood in terms of k
Poisson processes. The probability distribution for the waiting time for k hits is given
by
pk(t) = − ∂
∂t
P<k. (A.1)
The probability of at most k − 1 hits having occurred is given by
P<k(t) =
k−1∑
j=0
pi(j), (A.2)
where pi(j) = tje−t/j! is the Poisson distribution. The resulting distribution,
pk(t) =
tk−1e−t
(k − 1)! = pi(k − 1), (A.3)
matches the simulated rescaled waiting times tk/tmut very well, see Fig. 3 (a,b).
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